A Novel Biomarker in Diabetic Macular Edema with Serous Retinal Detachment: Serum Chitinase-3-Like Protein 1

2018 ◽  
Vol 241 (2) ◽  
pp. 90-97 ◽  
Author(s):  
Mahmut Kaya ◽  
Derya Kaya ◽  
Egemen Idiman ◽  
Nilufer Kocak ◽  
Taylan Ozturk ◽  
...  
Keyword(s):  
Retinal Detachment ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Serous Retinal Detachment

Automated detection of diabetic macular edema involving cystoids and serous retinal detachment

2020 ◽  
Vol 127 ◽  
pp. 106157
Author(s):  
Prashant Kumar Maurya ◽  
Vishal Gupta ◽  
Maninder Singh ◽  
Amit Kumar Singh ◽  
Basant Kumar ◽  
...  
Keyword(s):  
Retinal Detachment ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Serous Retinal Detachment ◽  
Automated Detection

Optical Coherence Tomography Features During the Evolution of Serous Retinal Detachment in Patients with Diabetic Macular Edema

2008 ◽  
Vol 145 (2) ◽  
pp. 289-296.e1 ◽  
Author(s):  
David Gaucher ◽  
Clemence Sebah ◽  
Ali Erginay ◽  
Belkacem Haouchine ◽  
Ramin Tadayoni ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Retinal Detachment ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Serous Retinal Detachment ◽  
Optical Coherence

scholarly journals Effects of dexamethasone treatment on serous retinal detachment in ranibizumab-resistant diabetic macular edema

2020 ◽  
Vol 12 ◽  
pp. 251584142097193
Author(s):  
Alper Halil Bayat ◽  
Mustafa Nuri Elçioğlu
Keyword(s):  
Retinal Detachment ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Serous Retinal Detachment ◽  
Dexamethasone Treatment ◽  
Intravitreal Dexamethasone Implant ◽  
Significant Difference ◽  
The Mean ◽  
Baseline Characteristics ◽  
Intravitreal Dexamethasone

Purpose: To evaluate outcome of intravitreal dexamethasone implant (IDI) treatment on serous retinal detachment (SRD) in patients with ranibizumab-resistant diabetic macular edema (DME). Materials and methods: Forty-eight eyes of 48 patients with DME resistant to ranibizumab were enrolled in this retrospective and comparative study. Patients were divided into two groups according to presence of serous retinal detachment: (1) SRD or (2) non-SRD groups. All patients had at least three monthly ranibizumab injections, after which they were treated with IDI. The best-corrected visual acuity (BCVA), central retinal thickness (CRT), use of antiglaucomatous drugs, and presence of cataract progression were noted at 1, 3, and 6 months post-IDI treatment. Results: There was not any statistically significant difference in terms of baseline characteristics of the patients. The mean CRT was declined in both groups at 1, 3, and 6 months ( p < 0.001). After IDI treatment, the mean BCVA was improved in both groups at 1, 3, and 6 months ( p < 0.001). When groups were compared, the change in CRT was higher in the SRD group ( p = 0.018), while there was no statistically significant difference between groups in terms of BCVA changes ( p = 0.448). Conclusion: The presence of SRD resulted in higher anatomical gain. SRD had no effects on visual changes after dexamethasone treatment in patients with ranibizumab-resistant DME.

scholarly journals Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment

2018 ◽  
Vol 32 (4) ◽  
pp. 296 ◽  
Author(s):  
Mahmut Kaya ◽  
Eyyup Karahan ◽  
Taylan Ozturk ◽  
Nilufer Kocak ◽  
Suleyman Kaynak
Keyword(s):  
Retinal Detachment ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Serous Retinal Detachment ◽  
Intravitreal Ranibizumab

scholarly journals Restoration of Foveal Bulge after Resolution of Diabetic Macular Edema with Coexisting Serous Retinal Detachment

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Yijun Hu ◽  
Qiaowei Wu ◽  
Baoyi Liu ◽  
Manqing Huang ◽  
Qingsheng Peng ◽  
...  
Keyword(s):  
Visual Acuity ◽  
Retinal Detachment ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Outer Nuclear Layer ◽  
Serous Retinal Detachment ◽  
Foveal Thickness ◽  
Central Foveal Thickness ◽  
Significant Difference ◽  
The Impact

Purpose. To evaluate the impact of restoration of foveal bulge (FB) in optical coherence tomography (OCT) images on visual acuity after resolution of diabetic macular edema with coexisting serous retinal detachment (SRD-DME). Methods. A total of 52 eyes with resolved SRD-DME and an intact ellipsoid zone at the central fovea were included. All eyes underwent best-corrected visual acuity (BCVA) examination and OCT scanning at baseline and follow-up visits (1, 3, and 6 months). The eyes were divided into two groups according to the presence of FB at 6 months. BCVA, central foveal thickness (CFT), height of SRD (SRDH), outer nuclear layer (ONL) thickness, photoreceptor inner segment (PIS), and outer segment (POS) length were compared between the two groups. Results. A FB was found in 25 of 52 (48%) eyes at 6 months. The FB (+) group had lower SRDH at baseline, and better BCVA, longer POS length at 6 months (all P<0.05). There was no significant difference in the CFT, ONL thickness, and PIS length at 6 months between the two groups (all P>0.05). More eyes in the FB (+) group had complete SRD resolution at 1 month (P=0.009) and 3 months (P=0.012). Eyes with complete SRD resolution at 1 month (P=0.009) or 3 months (P=0.012) were more likely to have a FB at 6 months. Conclusions. The Presence of the FB is associated with better BCVA after resolution of SRD-DME. Eyes with lower baseline SRDH or faster SRD resolution are more likely to have a FB at 6 months.

Sign in / Sign up

Export Citation Format

Share Document